Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00812890 · ClinicalTrials.gov registry record · Phase 1
Exploring Semi-Quantitative Pregnancy Tests and Their Impact on Reproductive Health Service Provision
A Phase 1 study, sponsored by Stanford University.
- Completed
- Registry status
- Phase 1
- Development phase
- 400
- Enrollment target
NCT00812890: Completed Phase 1 study, sponsored by Stanford University.
NCT00812890 is a Phase 1 study that has completed, run by Stanford University. The registered enrollment target is 400 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00812890, a Phase 1 study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 400 participants
- Enrollment target
Study Summary
This study will examine the feasibility, practicality, utility and usability of a semi-quantitative urine pregnancy test (dBest One Step hCG Panel Test Kit) recently approved by the food and drug administration (FDA) for both Professional (physician office) and over-the-counter (consumer) use. The study seeks to: 1. Assess the correlation of this pregnancy test results with serum values (as distinct from urine) hCG. 2. Assess whether or not time of day of urine collection has any impact on the outcome of the dBest test. 3. Assess user comprehension of the pregnancy test, especially assessment of the result.
Interventions
- DEVICE semi-quantitative pregnancy test
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 400 participants |
| Start Date | 2008-11 |
| Est. Completion | 2009-09 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00812890
The ClinicalTrials.gov registry entry for NCT00812890 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 400 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which semi-quantitative pregnancy test is the first listed.
NCT00812890 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00812890 about?
NCT00812890 is a clinical study titled "Exploring Semi-Quantitative Pregnancy Tests and Their Impact on Reproductive Health Service Provision". This study will examine the feasibility, practicality, utility and usability of a semi-quantitative urine pregnancy test (dBest One Step hCG Panel Test Kit) recently approved by the food and drug administration (FDA) for both Professional (physician office) and over-the-counter (consumer) use. The s...
What is the current status of trial NCT00812890?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 400 participants. The study started on 2008-11. Estimated completion is 2009-09.
What interventions are being tested in trial NCT00812890?
The interventions under investigation include: semi-quantitative pregnancy test (DEVICE).
Who is sponsoring clinical trial NCT00812890?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.